arginine has been researched along with ramipril in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (60.00) | 18.2507 |
2000's | 6 (20.00) | 29.6817 |
2010's | 6 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Auch-Schwelk, W; Bossaller, C; Claus, M; Fleck, E; Graf, K; Gräfe, M | 1 |
Becker, RH; Schölkens, BA; Wiemer, G | 1 |
Cachofeiro, V; Nasjletti, A; Sakakibara, T | 1 |
Busse, R; Fleming, I; Hecker, M | 1 |
Gögelein, H; Popp, R; Schölkens, BA; Wiemer, G | 1 |
Carretero, OA; Rhaleb, NE; Scicli, AG; Yang, XP | 1 |
Hartman, JC; Hullinger, TG; Kurc, GM; Shebuski, RJ; Sheehy, RM; Wall, TM | 1 |
Grötsch, H; Hropot, M; Klaus, E; Langer, KH; Linz, W; Schölkens, BA; Wiemer, G | 1 |
Hartman, JC | 1 |
Berkenboom, G; Brékine, D; Fontaine, J; Grosfils, K; Staroukine, M; Unger, P | 1 |
Cachofeiro, V; Lahera, V; Maeso, R; Navarro, J; Rodrigo, E; Ruilope, LM | 1 |
Hamann, M; Hegyi, I; Kaissling, B; Kurtz, A; Schricker, K | 1 |
Holmer, S; Krämer, BK; Kurtz, A; Riegger, G; Schricker, K | 1 |
Linz, W; Schölkens, BA; Wiemer, G | 1 |
Bara, AT; Busse, R; Hecker, M | 1 |
Cachofeiro, V; Guan, H; Kaminski, PM; Nasjletti, A; Pucci, ML; Wolin, MS | 1 |
Carretero, OA; Liu, YH; Sabbath, HN; Sharov, VG; Sigmon, DH; Yang, XP | 1 |
Chatterjee, K; Chou, TM; Hutchison, SJ; Sudhir, K | 1 |
Bellini, MA; Boschi, L; Forconi, S; Guerrini, M; Pallassini, A; Postorino, G; Richichi, MG; Trabalzini, L; Turchetti, V | 1 |
Kazdova, L; Komers, R; Pelikanova, T; Ruzickova, J; Simkova, R | 1 |
Brown, NJ; Davis, SN; Muldowney, JA; Vaughan, DE | 1 |
Bassal, S; Cooper, ME; Deemer, ER; El-Osta, A; Forbes, JM; Jerums, G; Long, DM; Osicka, TM; Panagiotopoulos, S; Pete, J; Thallas-Bonke, V; Thomas, MC; Thorpe, SR | 1 |
Brown, NJ; Muldowney, JA; Vaughan, DE | 1 |
Acikel, C; Caglar, K; Cakir, E; Eyileten, T; Kurt, Y; Oguz, Y; Saglam, M; Sonmez, A; Tasar, M; Vural, A; Yenicesu, M; Yilmaz, MI | 1 |
Axelsson, J; Caglar, K; Cayci, T; Eyileten, T; Kilic, S; Oguz, Y; Saglam, M; Sonmez, A; Vural, A; Yaman, H; Yenicesu, M; Yilmaz, MI | 1 |
Horowitz, JD; Kelly, DJ; Kennedy, JA; Ngo, DT; Qi, W; Smith, MD; Stafford, I; Sverdlov, AL; Weedon, H; Wuttke, RD; Zhang, Y | 1 |
Chan, WP; Chirkov, YY; Heresztyn, T; Horowitz, JD; Leslie, S; Liberts, EA; Procter, N; Rajendran, S; Willoughby, SR | 1 |
Brown, NJ; Gamboa, JL; Ikizler, TA; Pretorius, M; Sprinkel, KC | 1 |
1 review(s) available for arginine and ramipril
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 trial(s) available for arginine and ramipril
Article | Year |
---|---|
Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in Type 1 diabetes.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arginine; Blood Pressure; Citrulline; Cross-Over Studies; Diabetes Mellitus, Type 1; Drug Synergism; Hemodynamics; Hormones; Humans; Kidney; Losartan; Male; Nitric Oxide; Ramipril | 2004 |
NO synthase inhibition increases aldosterone in humans.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Arginine; Double-Blind Method; Enzyme Inhibitors; Female; Hemodynamics; Humans; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Potassium; Ramipril; Renin | 2004 |
Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Arginine; Double-Blind Method; Drug Combinations; Enzyme Inhibitors; Female; Fibrinolysis; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Plasminogen Activator Inhibitor 1; Prodrugs; Ramipril; Reference Values; Renin-Angiotensin System | 2006 |
Improving proteinuria, endothelial functions and asymmetric dimethylarginine levels in chronic kidney disease: ramipril versus valsartan.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Female; Glomerular Filtration Rate; Hemorheology; Humans; Insulin Resistance; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Proteinuria; Ramipril; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan; Vasodilation | 2007 |
Ramipril sensitizes platelets to nitric oxide: implications for therapy in high-risk patients.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Arginine; Biomarkers; Blood Platelets; Cohort Studies; Cyclic GMP; Double-Blind Method; Drug Administration Schedule; Female; Guanylate Cyclase; Humans; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Nitroprusside; Oxidative Stress; Platelet Aggregation; Ramipril; Thrombospondin 1 | 2012 |
Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis--a randomized cross-over study.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arginine; Bradykinin; Cell Line; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Ramipril; Renal Dialysis; Valsartan | 2015 |
23 other study(ies) available for arginine and ramipril
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Captopril; Cattle; Coronary Vessels; Dipeptides; Enalaprilat; Endothelium, Vascular; Fosinopril; Humans; In Vitro Techniques; Lisinopril; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroarginine; Ramipril; Receptors, Bradykinin; Receptors, Neurotransmitter; Vasodilation; Vasodilator Agents | 1992 |
Converting enzyme inhibitor-stimulated formation of nitric oxide and prostacyclin in endothelial cells from bovine aorta is mediated by endothelium-derived bradykinin.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arginine; Bradykinin; Captopril; Cattle; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Epoprostenol; Nitric Oxide; Nitroarginine; Ramipril | 1992 |
Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine; Biphenyl Compounds; Blood Pressure; Captopril; Hypertension; Imidazoles; Kinins; Losartan; Male; Nitric Oxide; omega-N-Methylarginine; Pyrroles; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1992 |
Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Calcium; Cattle; Cells, Cultured; Coronary Vessels; Cyclic GMP; Endothelium, Vascular; Epoprostenol; Humans; Isoquinolines; Nitric Oxide; Nitroarginine; Ramipril; Tetrahydroisoquinolines; Umbilical Veins; Vasodilation | 1993 |
Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cells.
Topics: 1-Methyl-3-isobutylxanthine; 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Calcium; Capillaries; Cells, Cultured; Cerebrovascular Circulation; Cyclic GMP; Cytosol; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Fura-2; Kinetics; Nitric Oxide; Nitroarginine; Ramipril; Swine | 1994 |
Role of kinins and nitric oxide in the antihypertrophic effect of ramipril.
Topics: Amino Acid Oxidoreductases; Animals; Aortic Coarctation; Arginine; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Heart Ventricles; Hypertension; Kinins; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Ramipril; Rats | 1994 |
Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat.
Topics: Amino Acid Oxidoreductases; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Blood Pressure; Female; Heart; Male; Myocardial Ischemia; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rabbits; Ramipril | 1994 |
Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: hypertension, cardiac hypertrophy and renal insufficiency.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Blood Pressure; Cardiomegaly; Cyclic GMP; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ramipril; Rats; Rats, Wistar; Renal Insufficiency; Ventricular Fibrillation | 1994 |
The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Topics: Adrenergic beta-Antagonists; Amino Acid Oxidoreductases; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Heart; Imidazoles; Losartan; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rabbits; Ramipril; Receptors, Angiotensin; Receptors, Bradykinin; Tetrazoles | 1995 |
Chronic angiotensin-converting enzyme inhibition and endothelial function of rat aorta.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arginine; Bradykinin; Cyclic GMP; Drug Synergism; Endothelium, Vascular; Hydralazine; Male; Nitric Oxide; omega-N-Methylarginine; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Wistar; Vasodilation | 1995 |
Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension.
Topics: Animals; Antihypertensive Agents; Arginine; Biphenyl Compounds; Blood Pressure; Bradykinin; Drug Interactions; Hypertension; Imidazoles; Indomethacin; Kidney Function Tests; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prostaglandins; Ramipril; Rats; Rats, Inbred SHR; Tetrazoles | 1995 |
Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin II.
Topics: Analysis of Variance; Angiotensin II; Animals; Arginine; Biphenyl Compounds; Enzyme Precursors; Enzyme Repression; Gene Expression Regulation, Enzymologic; Imidazoles; Indomethacin; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Ramipril; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrazoles | 1995 |
Control of renin gene expression in 2 kidney-1 clip rats.
Topics: Animals; Arginine; Denervation; Disease Models, Animal; Furosemide; Gene Expression Regulation; Hypertension, Renovascular; Kidney; Male; Meclofenamic Acid; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prostaglandin Antagonists; Ramipril; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger | 1994 |
Cardioprotective actions of bradykinin in myocardial ischemia and left ventricular hypertrophy.
Topics: Animals; Arginine; Bradykinin; Dogs; Endothelium, Vascular; Humans; Hypertrophy, Left Ventricular; Myocardial Ischemia; Nitroarginine; Ramipril; Rats | 1994 |
Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Cattle; Coronary Vessels; Cyclic GMP; Endothelium, Vascular; In Vitro Techniques; Isoquinolines; Nitric Oxide; Nitroarginine; Ramipril; Tetrahydroisoquinolines; Vasodilation | 1993 |
Nitric oxide and the depressor response to angiotensin blockade in hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Coarctation; Arginine; Biphenyl Compounds; Blood Pressure; Hypertension; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ramipril; Rats; Rats, Sprague-Dawley; Renin; Tetrazoles; Vasoconstrictor Agents | 1996 |
Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Arrhythmias, Cardiac; Bradykinin; Bradykinin Receptor Antagonists; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Hemodynamics; Indomethacin; Male; Myocardial Infarction; Myocardial Ischemia; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Ramipril; Rats; Rats, Inbred Lew; Reperfusion Injury | 1996 |
Coronary vasodilation induced by angiotensin-converting enzyme inhibition in vivo: differential contribution of nitric oxide and bradykinin in conductance and resistance arteries.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Coronary Vessels; Dogs; Echocardiography, Doppler; Indomethacin; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Ramipril; Vascular Resistance; Vasodilation | 1996 |
Haemorheological and endothelial-dependent alterations in heart failure after ACE inhibitor, calcium antagonist and beta blocker.
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Arginine; Blood Viscosity; Calcium; Carbazoles; Carvedilol; Citrulline; Erythrocytes; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide Synthase; Propanolamines; Ramipril; Time Factors; Treatment Outcome; Vascular Cell Adhesion Molecule-1; Vasodilator Agents | 2002 |
Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.
Topics: Alternative Splicing; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arginine; Blotting, Western; Cattle; Cells, Cultured; Collagen; Diabetic Nephropathies; DNA Primers; Endothelium, Vascular; Glycation End Products, Advanced; Humans; Immunohistochemistry; Immunoprecipitation; Kidney Cortex; Lysine; Male; Microscopy, Fluorescence; Molecular Weight; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; Skin; Time Factors; Up-Regulation | 2005 |
Reduced proteinuria using ramipril in diabetic CKD stage 1 decreases circulating cell death receptor activators concurrently with ADMA. A novel pathophysiological pathway?
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Arginine; Chronic Disease; Diabetic Nephropathies; fas Receptor; Female; Humans; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Myostatin; Proteinuria; Ramipril | 2010 |
Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve; Aortic Valve Stenosis; Arginine; Carrier Proteins; Disease Models, Animal; Disease Progression; Echocardiography; Enzyme Inhibitors; Ergocalciferols; Humans; Male; Rabbits; Ramipril; Vitamins | 2011 |